UZH-founded skin graft creator Cutiss has welcomed series A investors led by Giammaria Giuliani in a bid to provide improved healing of dermatological scars left by reconstructive or plastic surgery.

GCV Analytics defines the health sector as encompassing pharmaceuticals, medical and diagnostic devices, healthcare IT and administration, care provision and on-demand services as well as other health businesses.

Existing investor FoxKiser has returned for a $32.5m round that follows the cancer immunotherapy T cell developer's series A two years ago.

Stealth has secured $100m in convertible note financing across two rounds, one of which was led by Nan Fung Technology's Pivotal Beta.

Decibel Therapeutics, which is developing drugs to combat hearing loss, raised the cash in a round that included SR One, Regeneron and GV.

UCL and Syncona have both returned for Freeline's series B round, which will spur clinical development of the spinout's gene therapy for haemophilia B.

Existing investor FoxKiser has returned for a $32.5m round that follows the cancer immunotherapy T cell developer's series A two years ago.

Wearable sleep tracking device manufacturer Onera has raised an undisclosed sum after spinning off from TNO and nanoelectronics maker Imec.